Amitiza Oral Capsule 24Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Amitiza: Oral capsule (24mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_9033.JPG
Amitiza 24mcg Cap
Takeda Pharmaceuticals North America Inc
Pill Identification: SPI 

What is this Medicine?

LUBIPROSTONE (loo bi PROS tone) is a laxative. It is used to treat chronic constipation and constipation caused by opioids (certain prescription pain medicines). It is also used to treat adult women with irritable bowel syndrome who have constipation.

CVS Pharmacy Patient Statistics for Amitiza: Oral capsule(24mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Amitiza 24mcg Capsule

NDC: 647640240
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Constipation, Irritable Bowel Syndrome, Opiate Agonist-induced Constipation

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Amitiza 24mcg Capsule
Drug Image file DrugItem_9033.JPG
Takeda Pharmaceuticals North America Inc
Pill Identification: SPI 
Shape: capsule
Color: orange

Reported Side Effects for Amitiza 24mcg Capsule

Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Excessive Sweating Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Vomiting Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Fecal Incontinence Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Fecal Urgency Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
1.0-3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
2.0-11.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
4.0-8.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
7.0-12.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
8.0-29.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Amitiza

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.